U.S. stock futures remained steady Monday morning as investors wait for the Federal Reserve’s policy meeting to begin Tuesday. Economists are predicting that the Fed will delay paring back bond purchases because of economic uncertainty in the wake of the government shutdown. Data on industrial output and pending home sales are also due later on Monday.
Futures at 8:30 a.m.: DJIA: -0.06%, S&P 500: -0.06%, NASDAQ: +0.04%.
Here’s your cheat sheet to what’s buzzing this morning.
Boeing (NYSE:BA) may get a record-breaking order from the Dubai-based Emirates Airlines for up to 100 passenger jets. The deal could reach more than $30 billion, which would be Boeing’s biggest commercial order ever. Emirates — which, according to the Financial Times, operates the world’s largest fleet of wide-body passenger jets in the world — may order Boeing’s updated 777, called the 777X. The airline is also considering ordering jets from Boeing rival Airbus.
Apple (NASDAQ:AAPL) is due to report earnings after the closing bell on Monday. Analysts are expecting that earnings per share fell from $8.67 last year to $7.93, but revenue is expected to rise. Analysts are eager for data on sales of the new iPhones and Apple’s predictions for the holiday quarter. In particular, investors are curious about how the iPhone 5C, a quasi-lower cost version of the iPhone, performed versus the iPhone 5S to see if Apple missed the mark with the device.
Toyota (NYSE:TM) is still the world’s largest car manufacturer by volume, according to January-through-September sales data released by the Japanese automaker. Toyota beat out rivals General Motors (NYSE:GM) and Volkswagen (VLKAY.PK). Toyota’s strong sales in the U.S. pushed the automaker to unload 7.412 million vehicles in the year to date. General Motors came in second, with 7.25 million vehicles, and Volkswagen sold 7.03 million cars.
Celgene’s (NASDAQ:CELG) new arthritis drug has proven to be safe and highly effective during a trial of 527 patients who hadn’t been treated for arthritis before. The pill Apremilast, when taken twice a day, was found to notably reduce the signs and symptoms of psoriatic arthritis, and symptoms further improved after a year of taking the drug. Celegene’s drug is the first pill option for treating the disease, and will compete with injectable treatments currently available that have more serious side effects, according to Reuters. Celgene is expecting high sales from the treatment.
Follow Jacqueline on Twitter @Jacqui_WSCS
Don’t Miss: 7 Cars That Deliver Cool Under $20K.